/Companies

Septest

1 known investors

Find your way into Septest

Sign up to see every warm intro you have to Septest

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Septest team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Septest develops rapid point-of-need diagnostic tests for detecting infections and inflammation, including its multi-marker TRISEP test aimed at pre-hospital and community triage. The tools are intended for frontline healthcare professionals to speed sepsis detection and reduce antimicrobial resistance, with a focus on accessibility including in low- and middle-income countries.

Investors · 1

Frequently asked questions

What does Septest do?
Septest develops rapid point-of-need diagnostic tests for detecting infections and inflammation, including its multi-marker TRISEP test aimed at pre-hospital and community triage. The tools are intended for frontline healthcare professionals to speed sepsis detection and reduce antimicrobial resistance, with a focus on accessibility including in low- and middle-income countries.
Who are Septest's investors?
Septest's investors include Oxford Technology Management.